Sign in
BIOTU Stock Price, Chart, Stats & News
Biotech Acquisition Company
Save
Biotech Acquisition Company (BIOTU) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
BIOTU chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -77.12% |
ROA | -5279160.73% |
ROE | -121755.40% |
D/E | – |
Interest coverage ratio | -0.30x |
BIOTU valuation
P/E | – |
P/S | – |
P/B | -10740345.82x |
P/CF | -199.16x |
P/FCF | – |
P/OCF | -199.16x |
PEG | -0.24x |
EV multiple | -0.00x |
About
Biotech Acquisition Company presently does not conduct any substantial business operations. Its primary objective is to finalize a business combination, which might involve a merger, a share swap, an asset purchase, an equity acquisition, a corporate restructuring, or another comparable strategic transaction with one or more existing enterprises. This firm was established in 2020 and maintains its headquarters in New York, New York.
Similar securities
Based on sector and market capitalization
Report issue